HBM Healthcare Investments Aktie
WKN: 984345 / ISIN: CH0012627250
26.05.2023 06:30:21
|
Publication of Annual Report 2022/2023 and Invitation to the Ordinary Shareholders Meeting
HBM Healthcare Investments AG / Key word(s): AGMEGM The invitation to the 22nd Ordinary Shareholders Meeting on 19 June 2023 has been sent to the shareholders of HBM Healthcare Investments today. The detailed invitation with all motions of the Board of Directors is enclosed and displayed on the Companys website www.hbmhealthcare.com/en/investors/shareholders-meeting.
Contact End of Inside Information |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1642469 |
End of Announcement | EQS News Service |
|
1642469 26-May-2023 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
16.04.25 |
Key Figures 15.04.2025 (EQS Group) | |
01.04.25 |
HBM Healthcare Investments expects to report a net profit of CHF 19 million for the 2024/2025 financial year (EQS Group) | |
01.04.25 |
HBM Healthcare Investments erwartet Jahresgewinn von CHF 19 Millionen für das Geschäftsjahr 2024/2025 (EQS Group) | |
01.04.25 |
Key Figures 31.03.2025 (EQS Group) | |
20.03.25 |
Sanofi erwirbt DR-0201, ein klinisches Programm des HBM-Portfolio-Unternehmens Dren Bio, für einen Vorabbetrag von USD 600 Millionen, zuzüglich möglicher Meilensteine (EQS Group) | |
20.03.25 |
Sanofi to acquire DR-0201, a clinical-stage program of HBM portfolio company Dren Bio, for upfront amount of USD 600 million, plus potential milestones (EQS Group) | |
17.03.25 |
Key Figures 15.03.2025 (EQS Group) | |
03.03.25 |
Key Figures 28.02.2025 (EQS Group) |
Analysen zu HBM Healthcare Investments AGmehr Analysen
Aktien in diesem Artikel
HBM Healthcare Investments AG | 164,00 | 0,61% |
|